In vitro assessment of polyethylene glycol-coated iron oxide nanoparticles integrating luteinizing hormone releasing-hormone targeted magnetic hyperthermia and doxorubicin for lung and breast cancer cells
Biointerphases · 2025
DOI: 10.1116/6.0004228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biointerphases, 2025. Verfasst von Neha Srivastava und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala 147004, India. Hauptthemen laut MEDLINE: Doxorubicin, Polyethylene Glycols, Gonadotropin-Releasing Hormone, Hyperthermia, Induced. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Center of excellence in emerging materials.
Abstract (Originalsprache)
Magnetic nanoparticle-based targeted hyperthermia, combined with chemotherapy, is a promising approach for cancer treatment. In this study, a targeted magnetic drug delivery system was developed, comprising doxorubicin (DOX), a [D-Trp6] luteinizing hormone-releasing hormone (LHRH) (Triptorelin) ligand, and a polyethylene glycol (PEG)-coated magnetite core, aiming to enhance cancer therapy efficacy. Fourier-transform infrared spectroscopy confirmed the conjugation of LHRH onto the PEG-coated Fe3O4 nanoparticles. Ultraviolet–visible spectroscopy was employed to assess drug loading, revealing a loading efficiency of 66%. The DOX-loaded, LHRH-tagged PEG-coated Fe3O4 nanoparticles were evaluated for their cytotoxic effects on A549 and MCF-7 cancer cell lines under three treatment modalities: thermotherapy, chemotherapy, and combined thermo-chemotherapy, both with and without the application of a magnetic field. Cell viability was assessed using the 2,5-diphenyltetrazolium bromide (MTT) assay. In A549 cells, the combined thermo-chemotherapy treatment at a DOX concentration of 10 μg/ml resulted in an 88% reduction in cell viability, outperforming chemotherapy alone (62%) and thermotherapy alone (47%). Similarly, in MCF-7 cells, the combined treatment at 8 μg/ml DOX led to a 91% reduction in viability, surpassing the effects of chemotherapy (57%) and thermotherapy (45%) individually. Additionally, the targeted DOX-loaded nanoparticles significantly elevated interferon-gamma production, indicating an enhanced immune response and increased cancer cell apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala 147004, India.
- School of Physics and Materials Science, Thapar Institute of Engineering and Technology, Patiala 147004, India.
ORCID-Profile: Bhupendra Chudasama, Manoj Baranwal
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
- Center of excellence in emerging materials
Zitieren
APA
Srivastava, N., Chudasama, B., & Baranwal, M. (2025). In vitro assessment of polyethylene glycol-coated iron oxide nanoparticles integrating luteinizing hormone releasing-hormone targeted magnetic hyperthermia and doxorubicin for lung and breast cancer cells. Biointerphases. https://doi.org/10.1116/6.0004228
Vancouver
Srivastava N, Chudasama B, Baranwal M. In vitro assessment of polyethylene glycol-coated iron oxide nanoparticles integrating luteinizing hormone releasing-hormone targeted magnetic hyperthermia and doxorubicin for lung and breast cancer cells. Biointerphases. 2025. doi:10.1116/6.0004228
BibTeX
@article{Srivastava2025,
author = {Srivastava, Neha and Chudasama, Bhupendra and Baranwal, Manoj},
title = {In vitro assessment of polyethylene glycol-coated iron oxide nanoparticles integrating luteinizing hormone releasing-hormone targeted magnetic hyperthermia and doxorubicin for lung and breast cancer cells},
journal = {Biointerphases},
year = {2025},
doi = {10.1116/6.0004228}
}
EUVIMED